Order High-Sensitivity Cardiac Troponin (hs-cTn) for Chest Pain
For adults presenting with chest pain suggestive of acute coronary syndrome, order a high-sensitivity cardiac troponin assay (either hs-cTnI or hs-cTnT) rather than conventional troponin. 1
Why High-Sensitivity Troponin is Superior
High-sensitivity troponin assays have replaced conventional troponin as the standard of care because they:
- Enable faster rule-out protocols (0/1-hour or 0/2-hour pathways versus the older 0/3-hour protocols) 1
- Provide superior analytical precision at low concentrations, allowing detection of myocardial injury earlier in the disease course 2
- Reduce unnecessary observation time and testing when properly implemented in clinical pathways 3, 2
Recommended Testing Protocol
For Low-Risk Patients (HEART Score 0-3):
- Single hs-cTn measurement below validated threshold (typically <5 ng/L for most assays) can safely rule out ACS if symptoms >2-3 hours duration 1, 4
- Negative predictive value: 99.5-99.8% for 30-day MACE 4, 5
For All Other Patients:
- Serial hs-cTn testing at 0 and 2 hours with validated accelerated diagnostic pathway 1
- Alternative: 0 and 1-hour protocol (also guideline-supported) 6
- Negative serial results predict low rate of 30-day MACE, enabling safe ED discharge 1
Critical Implementation Details
Use assay-specific thresholds: Different hs-cTn assays (Abbott, Beckman, Siemens, Roche) have different cutoff values. The 99th percentile varies by manufacturer and sex 1. Your institution must validate thresholds for the specific assay in use.
Common pitfalls to avoid:
- Do not use conventional troponin with 0/3-hour protocols when hs-cTn is available—this delays diagnosis and discharge 1
- Do not apply hs-cTn protocols to patients with <2 hours of symptoms (insufficient time for troponin rise) 4
- Do not use hs-cTn alone without integrating ECG findings and clinical risk scores 1
Which Specific Assay?
Order whichever high-sensitivity troponin assay your institution has validated and implemented. The choice between hs-cTnI versus hs-cTnT matters less than ensuring:
- Your laboratory uses a true high-sensitivity assay (can measure troponin in ≥50% of healthy individuals)
- Validated risk-stratification thresholds are established for your specific assay
- Clinical pathways are properly implemented with appropriate timing protocols
Recent evidence shows successful implementation with various platforms including Abbott Access 3, Siemens Atellica 5, and others, with consistent safety profiles when protocols are followed correctly.
Post-Rule-Out Management
For patients with negative hs-cTn results and low HEART scores:
- Discharge from ED without routine stress testing or coronary CT angiography 1
- Arrange outpatient follow-up within 1-2 weeks 1
- Consider further testing only if no follow-up available 1
Implementation of hs-cTn with proper protocols increases ED discharge rates by approximately 4% while maintaining safety, particularly benefiting low-risk patients 3.